Product Information
DILTIAZEM 24H ER(CD) 240 MG CP is a generic product labeled by Major Pharmaceuticals, priced at $0.1969 per EA under NDC 00904721961. Its NADAC has been published 206 times since Oct 26, 2022.
FDA first approved this application on Aug 30, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
240 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904721961
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205231FDA Approved
8/30/2018
TE Code
AB3
On Market Since
8/9/2022
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 24H ER(CD) 240 MG CP has been published 206 times since Oct 26, 2022, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1969 per EA |
|---|---|
| All-time high | $0.3036 (Jul 10, 2024) |
| All-time low | $0.1900 (May 20, 2026) |
| 52-week high | $0.2162 |
| 52-week low | $0.1900 |
| Median price | $0.2222 |
| Average price | $0.2231 |
| Largest weekly change | +34.5% (Jun 19, 2024) |
| Weeks tracked | 206 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diltiazem hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 24H ER(CD) 240 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(CD) 240 MG CP, manufactured by Major Pharmaceuticals, is $0.1969 per EA (NDC 00904721961), effective Sep 30, 2026.
How has the price of DILTIAZEM 24H ER(CD) 240 MG CP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 24H ER(CD) 240 MG CP has declined 21.1%. It has been tracked across 206 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(CD) 240 MG CP?
Since Oct 26, 2022, the NADAC for DILTIAZEM 24H ER(CD) 240 MG CP has ranged from a low of $0.1900 (May 20, 2026) to a high of $0.3036 (Jul 10, 2024), with a median of $0.2222 per EA.
Are there cheaper alternatives to DILTIAZEM 24H ER(CD) 240 MG CP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 24H ER(CD) 240 MG CP in a comparable dosage form, but none are currently priced below it.
Who manufactures DILTIAZEM 24H ER(CD) 240 MG CP?
DILTIAZEM 24H ER(CD) 240 MG CP (NDC 00904721961) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.